149 related articles for article (PubMed ID: 31243109)
1. Contribution of Matrix Metalloproteinase-2 Promoter Genotypes to Nasopharyngeal Cancer Susceptibility and Metastasis in Taiwan.
Hsu SW; Gong CL; Hsu HM; Chao CC; Wang YC; Chang WS; Tsai YT; Shih LC; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2019; 16(4):287-292. PubMed ID: 31243109
[TBL] [Abstract][Full Text] [Related]
2. Contribution of
Tsai CW; Hsu HM; Wang YC; Chang WS; Shih LC; Sun KT; Hung YW; Yang YC; Gong CL; Bau DT
Anticancer Res; 2018 Dec; 38(12):6821-6826. PubMed ID: 30504396
[TBL] [Abstract][Full Text] [Related]
3. The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan.
Chen GL; Wang SC; Shen TC; Tsai CW; Chang WS; Li HT; Wu CN; Chao CY; Hsia TC; Bau DT
Chin J Physiol; 2019; 62(5):210-216. PubMed ID: 31670285
[TBL] [Abstract][Full Text] [Related]
4. Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.
Chen LH; Chiu KL; Hsia TC; Lee YH; Shen TC; Li CH; Shen YC; Chang WS; Tsai CW; Bau DT
In Vivo; 2020; 34(6):3181-3186. PubMed ID: 33144422
[TBL] [Abstract][Full Text] [Related]
5. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China.
Shao JY; Cao Y; Miao XP; Huang MY; Deng L; Hao JJ; Liang XM; Hu LF; Ernberg I; Lin DX; Zeng YX
Chin J Cancer; 2011 Sep; 30(9):620-6. PubMed ID: 21880183
[TBL] [Abstract][Full Text] [Related]
7. Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer.
Yueh TC; Hung YC; Lee HT; Yang MD; Wang ZH; Yang YC; Ke TW; Pei JS; Tsai CW; Bau DT; Chang WS
Anticancer Res; 2022 Nov; 42(11):5335-5342. PubMed ID: 36288896
[TBL] [Abstract][Full Text] [Related]
8. Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan.
Shih LC; Tsai CW; Chang WS; Shen TC; Wang YC; Yang JS; Lin ML; Wang ZH; Bau DT
Anticancer Res; 2020 Oct; 40(10):5503-5508. PubMed ID: 32988873
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population.
Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H
Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
Hu PS; Hsia NY; Wang ZH; Chen HC; Hsia TC; Lin ML; Wang YC; Chang WS; Bau DT; Tsai CW
In Vivo; 2024; 38(2):539-545. PubMed ID: 38418145
[TBL] [Abstract][Full Text] [Related]
11. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
12. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
14. Association of
Fu CK; Mong MC; Yu CC; Yang MD; Wang ZH; Yang YC; Chen JC; Pei JS; Hsia NY; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2022 Apr; 42(4):1749-1755. PubMed ID: 35346993
[TBL] [Abstract][Full Text] [Related]
15. The association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancer.
Shajarehpoor Salavati L; Tafvizi F; Manjili HK
Ir J Med Sci; 2017 Feb; 186(1):103-111. PubMed ID: 27541146
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
[TBL] [Abstract][Full Text] [Related]
17. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure.
Rahimi Z; Lotfi S; Ahmadi A; Jalilian N; Shakiba E; Vaisi-Raygani A; Rahimi Z
J Obstet Gynaecol; 2018 Apr; 38(3):327-332. PubMed ID: 29017408
[TBL] [Abstract][Full Text] [Related]
19. Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Kuo CC; Cheng SP; Tsai CW; Bau DT; Gong CL
Anticancer Res; 2019 Mar; 39(3):1185-1190. PubMed ID: 30842148
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
